Language Select
Varian Logo

INVESTOR RELATIONS

 

Investor Meeting at ASTRO

Monday, September 16, 2019
2:00pm CT
Listen to Webcast
Presentation

Varian Updates Investors on Proposed Reimbursement Changes

Thursday, August 8, 2019

Presentation

Third Quarter FY2019 Earnings Results Conference Call

Wednesday, July 24, 2019
1:30pm PDT

Listen to Webcast
Presentation
 

Recent News
Sep 16, 2019

Varian (NYSE: VAR) has named Francis R. Facchini, M.D., FSIR, as the new chief medical officer, Interventional Oncology, reporting to Dee Khuntia, Varian chief medical officer. Effective September...

Sep 16, 2019

Varian (NYSE: VAR) has been recognized again as a leader in the annual IMV ServiceTrak™ Radiation Oncology Systems report, ranking first in eight of the tracked categories. Additionally,...

Sep 16, 2019

Varian (NYSE: VAR) today announced its ProBeam 360° proton therapy system is now available in a multi-room configuration. The ProBeam 360° system is the smallest multi-room system available for...

More news >


Contact Investor Relations

Varian Corporate Headquarters
Tel: 650-424-5631
E-mail: investors@varian.com
IR Contacts

NYSE: VAR
NYSEVAR
  • Follow Us

Production of any of the material contained herein in any format or media without the express written permission of Varian Medical Systems is prohibited.

Varian Logo